EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Muco‐Penetrating Lipid Nanoparticles Having a Liquid Core for Enhanced Intranasal mRNA Delivery

Nipuni Maniyamgama iD, Ki Hyun Bae iD, Zi Wei Chang, Jialing Lee, Melgious J Y Ang, Yong Jie Tan, Lisa F P Ng, Laurent Renia, Kevin P White, Yi Yan Yang iD

Advanced Science · 2025-03 · 12 (11)

DOI: 10.1002/advs.202407383 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 30.01.2025. Verfasst von Nipuni Maniyamgama und 9 weiteren Autor:innen. Beteiligte Einrichtung: Bioprocessing Technology Institute (BTI), Agency for Science, Technology and Research (A*STAR), 20 Biopolis Way, Centros #06-01, Singapore, 138668, R…. Hauptthemen laut MEDLINE: Nanoparticles, RNA, Messenger, Lipids, COVID-19. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agency for Science, Technology and Research, National Medical Research Council, IAF-PP.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intranasal delivery of mRNA vaccines offers promising opportunities to combat airborne viruses like SARS‐CoV‐2 by provoking mucosal immunity, which not only defends against respiratory infection but also prevents contagious transmission. However, the development of nasal mRNA vaccines has been hampered by the lack of effective means to overcome the mucus barrier. Herein, ionizable lipid‐incorporated liquid lipid nanoparticles (iLLNs) capable of delivering mRNA cargo across airway mucosa are designed. Adjusting the ratios of ionizable and cationic lipids allows fine‐tuning of the p K a of iLLNs to the range of nasal mucosal pH (5.5–6.5), thus facilitating mucus penetration via the formation of near‐neutral, PEGylated muco‐inert surfaces. When nasally administered to mice, the top candidate iLLN‐2/mRNA complexes enable about 60‐fold greater reporter gene expression in the nasal cavity, compared to the benchmark mRNA‐lipid nanoparticles (ALC‐LNP) having the same lipid composition as that of BNT162b2 vaccine. Moreover, a prime‐boost intranasal immunization of iLLN‐2/mRNA complexes elicits a greater magnitude of SARS‐CoV‐2 spike‐specific mucosal IgA and IgG response than ALC‐LNP, without triggering any noticeable inflammatory reactions. Taken together, these results provide useful insights for the design of nasally deliverable mRNA formulations for prophylactic applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesRNA, MessengerLipidsCOVID-19Nasal MucosaCOVID-19 VaccinesAnimalsAdministration, IntranasalMiceSARS-CoV-2FemaleMice, Inbred BALB CHumansImmunity, MucosalLiposomes

Stichwörter der Autor:innen

intranasalionizableliquid lipid nanoparticlesmRNAmuco‐penetrating

Substanzen

RNA, MessengerLipidsCOVID-19 VaccinesLipid NanoparticlesLiposomes

Autor:innen und Institutionen

  • Bioprocessing Technology Institute (BTI), Agency for Science, Technology and Research (A*STAR), 20 Biopolis Way, Centros #06-01, Singapore, 138668, Republic of Singapore.
  • A*STAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science, Technology and Research (A*STAR), 8A Biomedical Grove, Immunos #05-13, Singapore, 138648, Republic of Singapore.
  • Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, 138648, Republic of Singapore.
  • School of Biological Sciences, Nanyang Technological University, Singapore, 138648, Republic of Singapore.
  • Department of Biochemistry and Precision Medicine Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119228, Republic of Singapore.

ORCID-Profile: Nipuni Maniyamgama, Ki Hyun Bae, Yi Yan Yang

Förderung

  • Agency for Science, Technology and Research
  • National Medical Research Council
  • IAF-PP

Zitieren

APA

Maniyamgama, N., Bae, K. H., Chang, Z. W., Lee, J., Ang, M. J. Y., Tan, Y. J., Ng, L. F. P., Renia, L., White, K. P., & Yang, Y. Y. (2025). Muco‐Penetrating Lipid Nanoparticles Having a Liquid Core for Enhanced Intranasal mRNA Delivery. Advanced Science, 12(11). https://doi.org/10.1002/advs.202407383

Vancouver

Maniyamgama N, Bae KH, Chang ZW, Lee J, Ang MJY, Tan YJ, et al. Muco‐Penetrating Lipid Nanoparticles Having a Liquid Core for Enhanced Intranasal mRNA Delivery. Advanced Science. 2025;12(11). doi:10.1002/advs.202407383

BibTeX
@article{Maniyamgama2025,
  author = {Maniyamgama, Nipuni and Bae, Ki Hyun and Chang, Zi Wei and Lee, Jialing and Ang, Melgious J Y and Tan, Yong Jie and Ng, Lisa F P and Renia, Laurent and White, Kevin P and Yang, Yi Yan},
  title = {Muco‐Penetrating Lipid Nanoparticles Having a Liquid Core for Enhanced Intranasal mRNA Delivery},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {11},
  doi = {10.1002/advs.202407383}
}
Kostenlos starten →